Zhang et al showed that incubating endometrial cancer cells with Δ‐9‐tetrahydrocannabinol, investigated in this context as a CB1 agonist, decreased the levels of MMP9 in an endometrial cancer model.47 The gene discussed is CNR1; the disease is endometrial cancer.